drugset / Trial / NCT00674453
The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation
RandomizedParallel-groupQuadruple-blindBasic science
Summary
The objective of the study is to demonstrate the effects that lasofoxifene has on serum markers of bone metabolism.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lasofoxifene | Small molecule | 0.25 mg | Oral |